Regulation of the long terminal repeat in visna virus by a transcription factor related to the AML/PEBP2/CBF superfamily

Virology

Volumn 229, Issue 1, 1997, Pages 240-250

  Sutton, Keith A ^a,c   Lin, Chung Tien ^b   Harkiss, Gordon D ^a   McConnell, Ian ^b   Sargan, David R ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; TRANSCRIPTION REGULATION; VIRUS REPLICATION; VISNA VIRUS;

ANIMALIA; MAEDI-VISNA VIRUS; VISNA VIRUS;

EID: 0031550786     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.8432     Document Type: Article

References (53)

1. Andresson, O. S., Elser, J. E., Tobin, G. J., Greenwood, J. D., Gonda, M. A., Georgsson, G., Andresdottir, V., Benediktsdottir, E., Carlsdottir, H. M., Mantyla, E. O., Rafnar, B., Palsson, P. A., Casey, J. W., and Petursson, G. (1993). Nucleotide sequence and biological properties of a pathogenic proviral molecular clone of neurovirulent visna virus. Virology 193, 89-105.
2. Bae, S-C., Ogawa, E., Maruyama, M., Oka, H., Satake, M., Shigesada, K., Jenkins, N. A., Gilbert, D. J., Copeland, N. G., and Ito, Y. (1994). PEBP2αB/mouse AML1 consists of multiple isoforms that possess different transactivation potentials. Mol. Cell. Biol. 14, 3242-3252.
3. Boral, A. L., Okenquist, S. A., and Lenz, J. (1989). Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element. J. Virol. 63, 76-84.
4. Brodie, S. J., Pearson, L. D., Zink, M. C., Bickle, H. M., Anderson, B. C., Marcom, K. A., and Demartini, J. C. (1995). Ovine lentivirus expression and disease. Virus replication, but not entry, is restricted to macrophages of specific tissues. Am. J. Pathol. 146, 250-263.
5. Cohen, D. R., Sinclair, A. H., and McGovern, J. D. (1994). SRY protein enhances transcription of Fos-related antigen 1 promoter constructs. Proc. Natl. Acad. Sci. USA 91, 4372-4376.
6. Du, W., Thanos, D., and Maniatis, T. (1993). Mechanisms of transcriptional synergism between distinct virus inducible enhancer elements. Cell 74, 887-898.
7. Faisst, S., and Meyer, S. (1992). Compilation of vertebrate encoded transcription factors. Nucleic Acids Res. 20, 3-26.
8. Fisher, F., and Goding, J. R. (1992). Single amino acid substitutions alter helix-loop-helix protein specificity for bases flanking the core CANNTG motif. EMBO J. 11, 4103-4109.
9. Gabuzda, D. H., Hess, J. L., Small, J. A., and Clements, J. E. (1989). Regulation of the visna virus long terminal repeat in macrophages involves cellular factors that bind sequences containing AP-1 sites. Mol. Cell. Biol. 9, 2728-2733.
10. Gdovin, S. L., and Clements, J. E. (1992). Molecular mechanisms of visna virus tat: Identification of the targets for transcriptional activation and evidence for a post translational effect. Virology 188, 438-450.
11. Gendelman, H. E., Narayan, O., Kennedy-Stoskopf, S., Kennedy, P. G. E., Ghotbi, Z., Clements, J. E., Stanley, J., and Pezeshkpour, G. (1986). Tropism of sheep lentiviruses for monocytes: Susceptibility to infection and virus gene expression increase during monocyte maturation to macrophages. J. Virol. 58, 67-74.
12. Gendelman, H. E., Narayan, O., Molineaux, S., Clements, J. E., and Ghotbi, Z. (1985). Slow persistent replication in lentiviruses: Role of macrophages and macrophage precursors in bone marrow. Proc. Natl. Acad. Sci. USA 82, 7086-7090.
13. Giese, K., Kingsley, C., Kirshner, J. R., and Grosschedl, R. (1995). Assembly and function of a TCRα enhancer complex is dependent on LEF-1 induced DNA bending and multiple protein-protein interactions. Genes Dev. 9, 995-1008.
14. Gilman, M. Z., Wilson, R. N., and Weinberg, R. A. (1986). Multiple protein-binding sites in the 5′-flanking region regulate c-fos expression. Mol. Cell. Biol. 6, 4305-4316.
15. Haase, A. T. (1986). Pathogenesis of lentivirus infections. Nature 322, 130-136.
16. Hess, J. L., Small, J. A., and Clements, J. E. (1989). Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral transactivation: Involvement of AP-1 sites in basal activity and transactivation. J. Virol. 63, 3001-3010.
17. Hsiang, Y. H., Spencer, D., Wang, S., Speck, N. A., and Raulet, D. H. (1993). The role of viral enhancer core motif-related sequences in regulating T-cell receptor-gamma and receptor-delta gene-expression. J. Immunol. 150, 3905-3916.
18. Jain, J., Valge-Archer, V. E., and Rao, A. (1992). Analysis of the AP-1 sites in the IL-2 promoter. Proc. Natl. Acad. Sci. USA 148, 1240-1250.
19. Kamaci, Y., Ogawa, E., Asano, M., Ishida, S., Murakami, Y., Satake, M., Ito, Y., and Shigesada, K. (1990). Purification of a mouse nuclear factor that binds to both the A and B cores of the polyoma virus enhancer. J. Virol. 64, 4808-4819.
20. Lee, W., Mitchell, P., and Tjian, R. (1987). Purified transcriptional factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49, 741-752.
21. Levanon, D., Bernstein, Y., Negreanu, V., Ghozi, M. C., Baram, I., Aloya, R., Goldenberg, D., Lotem, J., and Groner, Y. (1996). A large variety of alternatively spliced and differentially expressed messenger-RNAs are encoded by the human acute myeloid-leukemia gene AML1 DNA. Cell Biol. 15, 175-185.
22. Levanon, D., Negreanu, V., Bernstein, Y., Baram, I., Avivi, I., and Groner, Y. (1994). AML1, AML2 and AML3, the human members of the runt domain gene family: cDNA structure, expression and chromosomal localization. Genomics 23, 425-432.
23. Liebermann, D. A., and Hoffman, B. (1994). Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal haematopoietic cell differentiation. Stem Cells 12, 352-369.
24. Lord, K. A., Abdollahi, A., Hoffman-Liebermann, B., and Liebermann, D. A. (1993). Proto-oncogenes of the fos/jun familiy of transcription factors are positive regulators of myeloid differentiation. Mol. Cell. Biol. 13, 841-851.
25. Lord, K. A., Abdollahi, A., Hoffman-Liebermann, B., and Liebermann, D. A. (1990). Complexity of the early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, jun B and histone variants. Oncogene 5, 387-396.
26. Matsui, M., Tokuhara, M., Konuma, Y., Nomura, N., and Ishizaka, R. (1990). Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation. Oncogene 5, 249-255.
27. Melnikova, I. N., Crute, B. E., Wang, S., and Speck, N. A. (1993). Sequence specificity of the core binding factor. J. Virol. 67, 2408-2411.
28. Meyers, S., Lenny, N., and Hiebert, S. W. (1996). AML-2 is a potential target for transcriptional regulation by the t(8:21) and t(12:21) fusion proteins in acute leukemia. Oncogene 13, 303-312.
29. Miyoshi, H., Shimuzi, K., Kozu, T., Maseki, N., Kaneko, Y., and Ohki, M. (1991). t(8:21) breakpoints on chromasome 21 are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA 88, 10431-10434.
30. Narayan, O., Kennedy-Stoskopf, S., Sheffer, D., Griffen, D. E., and Clements, J.E. (1983). Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect. Immun. 41, 67-73.
31. Natesan, S., and Gilman, M. Z. (1993). DNA bending and orientation-dependent function of YY1 in the c-fos promoter. Genes Dev. 7, 2497-2509.
32. Neuveut, C., Vigne, R., Clements, J. E., and Sire, J. (1993). The visna transactivatot TAT: Effects on the viral LTR and on cellular genes. Virology 197, 236-244.
33. Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., and Ito, Y. (1993). PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and human AML-1 gene. Proc. Natl. Acad. Sci. USA 90, 6859-6863.
34. Parslow, T. G., Blair, D. L., Murphy, W. J., and Granner, D. K. (1984). Structure of the 5′ ends of immunoglobulin genes: A novel conserved sequence. Proc. Natl. Acad. Sci. USA 81, 2650-2654.
35. Querat, G., Audoly, G., Sonigo, P., and Vigne, R. (1990). Nucleotide sequence analysis of SA-OMVV, a visna related lentivirus: Phylogenetic history of lentiviruses. Virology 175, 434-447.
36. Redondo, J. M., Pfohl, J. L., and Krangel, M. S. (1991). Identification of an essential site for transcriptional activation within the human T-cell receptor δ enhancer. Mol. Cell. Biol. 11, 5671-5680.
37. Ryseck, R. P., and Bravo, R. (1991). c-Jun, JunB and JunD differ in their binding affinities to AP-1 and CRE consensus sequences: Effects of fos proteins. Oncogene 6, 533-542.
38. Saltarelli, M., Querat, G., Konings, D. A. M., Vigne, R., and Clements, J. E. (1990). Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology 179, 347-364.
39. Sargan, D. R., Bennet, I. D., Cousens, C., Roy, D. J., Blacklaws, B. A., Dalziel, R. G., Watt, N. J., and McConnell, I. (1991). Nucleotide sequence of EV1, a British isolate of maedi-visna virus. J. Gen. Virol. 72, 1893-1903.
40. Sargan, D. R., Sutton, K. A., Bennet, I. D., McConnell, I., and Harkiss, G. D. (1995). Sequence and repeat structure variants in the long terminal repeat of maedi-visna virus EV1. Virology 208, 343-348.
41. Schreiber, E., Matthias, P., Muller, M. M., and Schaffner, W. (1989). Rapid detection of octamer binding proteins with "mini extracts," prepared from a small number of cells. Nucleic Acids Res. 17, 6419.
42. Seed, B., and Sheen, J-Y. (1988). A simple phase extraction assay for chloramphenicol acetyltransferase activity. Gene 67, 271-277.
43. Shih, D. S., Carruth, L. M., Anderson, M., and Clements, J. E. (1992). Involvement of fos and jun in the activation of visna virus gene expression in macrophages through an AP-1 site in the viral LTR Virology 190, 84-91.
44. Sigurdsson, B., Palsson, P. A., and Grimsson, H. (1957). Visna, ademyelinating transmissible disease of sheep. J. Neuropathol. Exp. Neurol. 16, 389-403.
45. Sigurdsson, B., and Palsson, P. A. (1958). Visna of sheep. A slow demyelinating infection. Brit. J. Exp. Pathol. 39, 519-528.
46. Small, J. A., Bieberich, C., Ghotbi, Z., Hess, J., Scangos, G. A., and Clements, J. E. (1989). The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes and the central nervous system of transgenic mice. J. Virol. 63, 1891-1896.
47. Sonigo, P., Alizon, M., Staskus, K., Klatzman, Cole, S., Danos, O., Retzel, E., Ticollais, P., Haase, A., and Wain-Hobson, S. (1985). Nucleotide sequence of the visna lentivirus: Relationship to the AIDS virus. Cell 42, 369-382.
48. Takahashi, A., Satake, M., Yamaguchiiwai, Y., Bae, S. C., Maruyama, M., Zhang, Y. W., Oka, H., Arai, N., Arai, K., and Ito, Y. (1995). Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood 86, 607-616.
49. Thanos, D., and Maniatis, T. (1992). The high mobility group protein HMGI (Y) is required for NF-κB dependent virus induction of the human IFN-β. Cell 71, 777-789.
50. Thornell, A., Hallberg, B., and Grundstrom, T. (1988). Differential protein binding in lymphocytes to a sequence in the enhancer of mouse retrovirus SL3-3. Mol. Cell. Biol. 8, 1625-1637.
51. Tjian, R., and Maniatis, T. (1994). Transcriptional activation: A complex puzzle with few easy pieces. Cell 77, 5-8.
52. Wang, S., and Speck, N. A. (1992). Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancer. Mol. Cell. Biol. 12, 89-102.
53. Wang, S., Wang, Q., Crute, B. E., Melnikova, I. N., Keller, S. R., and Speck, N. A. (1993). Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13, 3242-3252.